Basic Information
Basic information for SNHG14-329-10aa-2
Peptide Name SNHG14-329-10aa-2
Genome Position chr15:25419610-25419639[+]
Species Human
Peptide Sequence MKVNIKECYS
Peptide Length 10
Unique No (SNHG14-203-10aa-3,SNHG14-226-10aa-2,SNHG14-228-10aa-2,SNHG14-229-10aa-2,SNHG14-244-10aa-4,SNHG14-245-10aa-2,SNHG14-266-10aa-2,SNHG14-284-10aa-2,SNHG14-285-10aa-2,SNHG14-292-10aa-2,SNHG14-294-10aa-2,SNHG14-295-10aa-2,SNHG14-306-10aa-3,SNHG14-320-10aa-2,SNHG14-328-10aa-3,SNHG14-331-10aa-2)
Grand Average of Hydropathicity -0.38
Relative Molecular Mass 1376.6
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000224078;SNHG14
Transcript ID/Name ENST00000669989;SNHG14-329
Transcript Length 6336
Coding Ability 0.5073
DNA Sequence Corresponding to Peptide ATGAAGGTAAATATAAAGGAATGTTATTCT
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :